Tag: machine learning

GoCheck Kids CEO Kevon Saber shares vision with pediatricians

December 17th, 2020 by

Kevon Saber photo
Kevon Saber, GoCheck Kids CEO

Vision impairment is the most common disability for children, and it’s usually very treatable if detected early. But pediatricians struggle with vision screening. Wall charts are cumbersome to administer and as a result practices take shortcuts and miss a lot of cases. Kevon Saber is on a mission to change that. GoCheck Kids, where he’s CEO, uses a smartphone based tool for easy vision screening that integrates with the electronic health record.

In this episode of the HealthBiz Podcast, Kevon traces his journey as the son of Persian and Mexican parents living in immigrant neighborhoods, through Santa Clara University, Stanford, Silicon Valley and now Nashville. Many of the kids he grew up with have struggled –some are dead or in prison. Meanwhile, Kevon is a proponent of diversity in healthcare leadership, and wants his team to reflect the communities they serve.

Kevon is re-reading (or listening to) a few books:

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle Podcasts and  many more services. Please consider rating the podcast on Apple Podcasts. Doing so helps the podcast reach more listeners.

Check out the rough (AI generated) transcript of the episode. Click on a word if you want to start the podcast from a particular spot.


By healthcare business consultant David E. Williams, president of Health Business Group

Medial EarlySign: machine learning for population health (podcast)

July 7th, 2017 by

Medial EarlySign analyzes standard EHR data to identify individuals at high risk for disease. The company’s first solution, ColonFlag uses longitudinal blood test data to identify patients who are at high risk for colorectal cancer.

I spoke recently with Medial executive Tomer Amit, who filled me in on the company’s approach and explained why the company has been named a Cool Vendor in AI by Gartner.

  • (0:15) What unmet need are you serving?
  • (1:05) You talk about using data that’s already available. What kind of data?
  • (3:02) When you mention “historical data” are you talking about longitudinal data for an individual patient or aggregated data for a population?
  • (4:18) Why is colorectal cancer an initial focus for the company, with your ColonFlag solution?
  • (5:13) Does ColonFlag replace colonoscopy or encourage someone to get one if they have an indicator that they are at greater risk?
  • (6:38) I see how it could help an individual. Would it actually help at the population level?
  • (7:45) You started in Israel and the EU, which have strong longitudinal medical records. Can the approach be applied in the US where that’s not the case?
  • (10:41) You have run your tests in different places around the world. Does the model differ by population or is there a universal algorithm?
  • (12:10) How do you protect your intellectual property? Once you are out there, are there just rules of thumb people can use instead of working with you?
  • (13:14) What traction have you gained with customers or partners? What industry recognition have you received?
  • (14:45) Are there other domains you are investigating beyond colon cancer? Other data beyond blood tests?
  • (15:58) What’s your 5-10 year vision of what’s possible and what Medial’s role will be?

By healthcare business consultant David E. Williams, president of Health Business Group.